{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:01:54Z","timestamp":1777438914837,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.6061\/clinics\/2012(07)03","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T10:17:54Z","timestamp":1343038674000},"page":"711-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"67","author":[{"given":"Helena Atroch","family":"Machado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia Regina Soares","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Tsunechiro","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalva Marreiro","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo Leo","family":"Wajchenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia G.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elizabeth Rossi","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.6061\/clinics\/2012(07)03_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.12.004","article-title":"Glycemic control and complications in type 2 diabetes mellitus","volume":"123","author":"Stolar","year":"2010","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.6061\/clinics\/2012(07)03_bib2","first-page":"S13","article-title":"American Diabetes Association- Standards of medical care in diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.6061\/clinics\/2012(07)03_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diabetes and Vascular Disease Research"},{"issue":"3","key":"10.6061\/clinics\/2012(07)03_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10557-008-6092-0","article-title":"Metformin: Effects on micro and macro vascular complications in type 2 diabetes","volume":"22","author":"Bailey","year":"2008","journal-title":"Cardiovascular Drugs Ther"},{"issue":"9","key":"10.6061\/clinics\/2012(07)03_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-2007-979830","article-title":"Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide","volume":"28","author":"Draeger","year":"1996","journal-title":"Horm Metab Res"},{"issue":"7","key":"10.6061\/clinics\/2012(07)03_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1463-1326.2008.00870.x","article-title":"Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin","volume":"10","author":"Mori","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.6061\/clinics\/2012(07)03_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diabres.2008.09.004","article-title":"Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study","volume":"82","author":"Sadikot","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.6061\/clinics\/2012(07)03_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/dmrr.642","article-title":"Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin","volume":"22","author":"Monami","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"10.6061\/clinics\/2012(07)03_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/BF00400658","article-title":"Interaction of sulfonylurea derivate with vascular ATP-sensitive potassium channels in humans","volume":"39","author":"Bijlstra","year":"1996","journal-title":"Diabetologia"},{"issue":"6","key":"10.6061\/clinics\/2012(07)03_bib10","first-page":"439","article-title":"Sulfonylureas and ischemic preconditioning","volume":"20","author":"Klepzig","year":"1999","journal-title":"A double-blind, placebo controlled evaluation of glimepiride and glibenclamide. European Heart Journal"},{"issue":"2","key":"10.6061\/clinics\/2012(07)03_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1210\/jc.2002-020904","article-title":"Impairment of myocardial protection in type 2 diabetic patients","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(07)03_bib12","first-page":"136","article-title":"Vascular effects of glibenclamide vs","volume":"19","author":"Abbink","year":"2002","journal-title":"glimepiride and metformin in Type 2 diabetic patients. Diabet Med"},{"issue":"4","key":"10.6061\/clinics\/2012(07)03_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2337\/diacare.24.4.738","article-title":"Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia","volume":"24","author":"Spallarossa","year":"2001","journal-title":"Diabetes Care"},{"issue":"12","key":"10.6061\/clinics\/2012(07)03_bib14","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2005.03.041","article-title":"Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study","volume":"45","author":"Pf\u00fctzner","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.6061\/clinics\/2012(07)03_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000215722","article-title":"Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications","volume":"18","author":"Yener","year":"2009","journal-title":"Effects of metformin and rosiglitazone. Med Princ Pract"},{"issue":"3 Pt 1","key":"10.6061\/clinics\/2012(07)03_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1262-3636(07)70192-1","article-title":"Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study","volume":"31","author":"Rizzo","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.6061\/clinics\/2012(07)03_bib17","first-page":"143","article-title":"Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin","volume":"17","author":"Derosa","year":"2004","journal-title":"Diabetes Nutr Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(07)03_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0149-2918(03)80090-5","article-title":"Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"issue":"1","key":"10.6061\/clinics\/2012(07)03_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0149-2918(03)90025-7","article-title":"Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study","volume":"25","author":"Luis","year":"2003","journal-title":"Clin Ther"},{"issue":"2","key":"10.6061\/clinics\/2012(07)03_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.6061\/clinics\/2012(07)03_bib21","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/clinchem\/21.12.1754","article-title":"Evaluations of Trinder's glucose oxidase method for measuring glucose in serum and urine","volume":"21","author":"Latt","year":"1975","journal-title":"Clin Chem"},{"key":"10.6061\/clinics\/2012(07)03_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM197102182840703","article-title":"Hemoglobin components in patients with diabetes mellitus","volume":"284","author":"Trivelli","year":"1971","journal-title":"New Engl J Med"},{"key":"10.6061\/clinics\/2012(07)03_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","article-title":"Enzymatic methods for quantification of lipoprotein lipids","volume":"129","author":"Warnick","year":"1986","journal-title":"Methods Enzymol"},{"issue":"1","key":"10.6061\/clinics\/2012(07)03_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/clinchem\/36.1.15","article-title":"Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints","volume":"36","author":"Warnick","year":"1990","journal-title":"Clin Chem"},{"issue":"Pt 2","key":"10.6061\/clinics\/2012(07)03_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/000456328502200217","article-title":"Methodological considerations in the determination of plasma cathecolamines by high-performance liquid chromatography with electrochemical detection","volume":"22","author":"Bouloux","year":"1985","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.6061\/clinics\/2012(07)03_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Rapid physiological coagulation method for determination of fibrinogen","volume":"17","author":"Clauss","year":"1957","journal-title":"Acta Haematol"},{"key":"10.6061\/clinics\/2012(07)03_bib27","first-page":"67","article-title":"Quantitative investigation into the aggregation of blood platelets","volume":"162","author":"Born","year":"1962","journal-title":"J Physiol"},{"key":"10.6061\/clinics\/2012(07)03_bib28","series-title":"Handbook of Statistics. Volume 18: Bio-Environmental and Public Health Statistics","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0169-7161(00)18007-1","article-title":"Analysis of longitudinal data","author":"Singer","year":"2000"},{"key":"10.6061\/clinics\/2012(07)03_bib29","series-title":"Applied Linear Statistical Models","author":"Neter","year":"1996"},{"issue":"8","key":"10.6061\/clinics\/2012(07)03_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1440-1681.2008.04920.x","article-title":"Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study","volume":"35","author":"Meaney","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.6061\/clinics\/2012(07)03_bib31","doi-asserted-by":"crossref","first-page":"445.e1","DOI":"10.1016\/j.ahj.2006.11.005","article-title":"A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes","volume":"153","author":"Stocker","year":"2007","journal-title":"Am Heart J"},{"issue":"3","key":"10.6061\/clinics\/2012(07)03_bib32","first-page":"367","article-title":"Effects of rosiglitazone on the IMTc and serum MMP-9 levels in newly diagnosed type 2 diabetic patients","volume":"31","author":"Huang","year":"2006","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"10.6061\/clinics\/2012(07)03_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/hrt.2003.027722","article-title":"Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomized study","volume":"91","author":"Stakos","year":"2005","journal-title":"Heart"},{"issue":"9","key":"10.6061\/clinics\/2012(07)03_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2007-979835","article-title":"The effect of glimepiride on pancreatic beta – cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non insulin. dependent diabetes mellitus","volume":"28","author":"Clark","year":"1996","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.6061\/clinics\/2012(07)03_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1507\/endocrj.47.763","article-title":"Chronic sulfonylurea treatment and hyperglycemia aggravate disproportionately elevated plasma proinsulin levels in patients with 2 diabetes","volume":"47","author":"Inoguchi","year":"2000","journal-title":"Endocr J"},{"issue":"5","key":"10.6061\/clinics\/2012(07)03_bib36","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1172\/JCI32133","article-title":"Pharmacogenetics of metformin response: a step in the path toward personalized medicine","volume":"117","author":"Reitman","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"10.6061\/clinics\/2012(07)03_bib37","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.90295.2008","article-title":"Insulin as a physiological modulator of glucagon secretion","volume":"295","author":"Bansal","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4 Pt","key":"10.6061\/clinics\/2012(07)03_bib38","first-page":"6S44","article-title":"Beneficial effects of metformin on haemostasis and vascular function in man","volume":"29","author":"Grant","year":"2003","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(07)03_bib39","first-page":"109","article-title":"Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system","volume":"117","author":"Wing","year":"1991","journal-title":"J Lab Clin Med"},{"issue":"21","key":"10.6061\/clinics\/2012(07)03_bib40","first-page":"1892","article-title":"For the Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators","volume":"170","author":"Roussel","year":"2010","journal-title":"Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis. Arch Intern Med"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222017628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222017628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-7\/cln-67-07-711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:07:40Z","timestamp":1761721660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222017628"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012000700003&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3400159\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1807593222017628"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(07)03","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(07)03","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}